Regencell Bioscience Holdings RGC
NASDAQ RGC
$6.17 -0.03 (-0.48%)
As of: Sep 30, 2026 · 10:20 AM EDT

Regencell Bioscience Holdings (RGC) Notes Payables (2021 - 2025)

Updated

Regencell Bioscience Holdings' Notes Payables came in at $106.00 for the quarter ended Dec 31, 2025.

Analysis

Regencell Bioscience Holdings (RGC) Notes Payables (2021 - 2025) Analysis & Trends

As of Jun 30, 2025, Regencell Bioscience Holdings' Notes Payables was $2,539, down 69.9% from the prior year.

  • Notes Payables has declined in each of the last four years, with a four-year compound annual growth rate of -83.3% (years ended Jun 2021 to Jun 2025).
  • Going back by year, Notes Payables was $8,443 in the year ended Jun 30, 2024 (-20.1%), $10,570 in the year ended Jun 30, 2023 (-32.5%), $15,650 in the year ended Jun 30, 2022 (-99.5%) and $3.25 million in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Regencell Bioscience Holdings 80.68 Mn 73.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 106.00
Jun 30, 2025 2,539.00
Jun 30, 2024 8,443.00
Jun 30, 2023 10,570.00
Jun 30, 2022 15,650.00
Jun 30, 2021 3.25 Mn
API Access

Regencell Bioscience Holdings Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=RGC&period=max&api_key=YOUR_API_KEY